BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei R, Cui X, Feng J, Gu L, Lang S, Wei T, Yang J, Liu J, Le Y, Wang H, Yang K, Hong T. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice. Metabolism. 2020;111:154324. [PMID: 32712220 DOI: 10.1016/j.metabol.2020.154324] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Nakamura A. Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function. Int J Mol Sci 2022;23:5104. [PMID: 35563495 DOI: 10.3390/ijms23095104] [Reference Citation Analysis]
2 Kaneto H, Obata A, Kimura T, Shimoda M, Kinoshita T, Matsuoka TA, Kaku K. Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class. Int J Mol Sci 2021;22:3062. [PMID: 33802741 DOI: 10.3390/ijms22063062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ghosh A, Dutta K, Bhatt SP, Gupta R, Tyagi K, Ansari IA, Venugopal VK, Mahajan H, Pandey RM, Pandey S, Misra A. Dapagliflozin Improves Body Fat Patterning, and Hepatic and Pancreatic Fat in Patients With Type 2 Diabetes in North India. J Clin Endocrinol Metab 2022;107:e2267-75. [PMID: 35263436 DOI: 10.1210/clinem/dgac138] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cui X, Feng J, Wei T, Gu L, Wang D, Lang S, Yang K, Yang J, Yan H, Wei R, Hong T. Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice. iScience 2022;25:104567. [DOI: 10.1016/j.isci.2022.104567] [Reference Citation Analysis]
5 El-shafey M, El-agawy MSE, Eldosoky M, Ebrahim HA, Elsherbini DMA, El-sherbiny M, Asseri SM, Elsherbiny NM. Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis. Front Endocrinol 2022;13:862394. [DOI: 10.3389/fendo.2022.862394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tian K, Xia C, Liu H, Xu B, Wei P, Fu W, Lu M, Li Y, Li Y, Cheng D, Liu E, Zhao S. Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms. J Immunol Res 2021;2021:6297332. [PMID: 34825008 DOI: 10.1155/2021/6297332] [Reference Citation Analysis]
7 Wang KL, Tao M, Wei TJ, Wei R. Pancreatic β cell regeneration induced by clinical and preclinical agents. World J Stem Cells 2021; 13(1): 64-77 [PMID: 33584980 DOI: 10.4252/wjsc.v13.i1.64] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Luo ZC, Jin ZR, Jiang YF, Wei TJ, Cao YL, Zhang Z, Wei R, Jiang H. The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction. Asian J Androl 2022. [PMID: 35848706 DOI: 10.4103/aja202242] [Reference Citation Analysis]
9 Newsholme P, Rowlands J, Rose’meyer R, Cruzat V. Metabolic Adaptions/Reprogramming in Islet Beta-Cells in Response to Physiological Stimulators—What Are the Consequences. Antioxidants 2022;11:108. [DOI: 10.3390/antiox11010108] [Reference Citation Analysis]
10 Matthews JR, Schlaich MP, Rakoczy EP, Matthews VB, Herat LY. The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy. Biomedicines 2022;10:522. [DOI: 10.3390/biomedicines10030522] [Reference Citation Analysis]
11 Čertíková Chábová V, Zakiyanov O. Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes. Int J Mol Sci 2022;23:2812. [PMID: 35269954 DOI: 10.3390/ijms23052812] [Reference Citation Analysis]
12 Khin PP, Lee JH, Jun HS. A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes. Nutrients 2021;13:1593. [PMID: 34068827 DOI: 10.3390/nu13051593] [Reference Citation Analysis]
13 Kaneto H, Kimura T, Shimoda M, Obata A, Sanada J, Fushimi Y, Nakanishi S, Mune T, Kaku K. Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: "The Earlier, the Better" in Therapy with Incretin-Based Medicine. Int J Mol Sci 2021;22:7917. [PMID: 34360682 DOI: 10.3390/ijms22157917] [Reference Citation Analysis]
14 Tsai KF, Chen YL, Chiou TT, Chu TH, Li LC, Ng HY, Lee WC, Lee CT. Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases. Antioxidants (Basel) 2021;10:1166. [PMID: 34439414 DOI: 10.3390/antiox10081166] [Reference Citation Analysis]
15 Lingli X, Wenfang X. Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review. Life Sci 2022;:120543. [PMID: 35421452 DOI: 10.1016/j.lfs.2022.120543] [Reference Citation Analysis]
16 Shyr ZA, Yan Z, Ustione A, Egan EM, Remedi MS. SGLT2 inhibitors therapy protects glucotoxicity-induced β-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress. PLoS One 2022;17:e0258054. [PMID: 35180212 DOI: 10.1371/journal.pone.0258054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wei T, Wei R, Hong T. Regeneration of β cells from cell phenotype conversion among the pancreatic endocrine cells. Chronic Diseases and Translational Medicine. [DOI: 10.1002/cdt3.15] [Reference Citation Analysis]
18 Liu H, Wei P, Fu W, Xia C, Li Y, Tian K, Li Y, Cheng D, Sun J, Xu Y, Lu M, Xu B, Zhang Y, Wang R, Wang W, Xu B, Liu E, Zhao S, Yu Q. Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-11. [DOI: 10.1155/2022/8502059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Fushimi Y, Obata A, Sanada J, Nogami Y, Ikeda T, Yamasaki Y, Obata Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice. Sci Rep 2021;11:16120. [PMID: 34373487 DOI: 10.1038/s41598-021-94896-w] [Reference Citation Analysis]